Table of Content

1. Executive Summary
   1. Global Hepatitis C Treatment Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Tool Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Deployment Costs
   3. Pricing Analysis, By Treatment Type
5. Global Hepatitis C Treatment Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Global Hepatitis C Treatment Market Outlook: Treatment Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Treatment Type, 2019 - 2024
      3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
         1. Direct-Acting Antivirals
         2. Interferon-Based Therapies
         3. Supportive/Adjunct Therapies
         4. Diagnostics-Plus-Drug Packages
      4. Market Attractiveness Analysis: Treatment Type
   4. Global Hepatitis C Treatment Market Outlook: Clinical Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Clinical Indication, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
         1. Pan-Genotypic
         2. Genotype-Specific
         3. Acute
         4. Chronic
         5. Pediatric
         6. Adult
      4. Market Attractiveness Analysis: Clinical Indication
   5. Global Hepatitis C Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Public Health Programs & Tenders
         2. Hospitals & Specialty Clinics
         3. Primary Care & Decentralized Clinics
         4. Retail Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
6. Global Hepatitis C Treatment Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America Hepatitis C Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Clinical Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Direct-Acting Antivirals
      2. Interferon-Based Therapies
      3. Supportive/Adjunct Therapies
      4. Diagnostics-Plus-Drug Packages
   5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
      1. Pan-Genotypic
      2. Genotype-Specific
      3. Acute
      4. Chronic
      5. Pediatric
      6. Adult
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Public Health Programs & Tenders
      2. Hospitals & Specialty Clinics
      3. Primary Care & Decentralized Clinics
      4. Retail Pharmacies
   7. Market Attractiveness Analysis
8. Europe Hepatitis C Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Clinical Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Direct-Acting Antivirals
      2. Interferon-Based Therapies
      3. Supportive/Adjunct Therapies
      4. Diagnostics-Plus-Drug Packages
   5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
      1. Pan-Genotypic
      2. Genotype-Specific
      3. Acute
      4. Chronic
      5. Pediatric
      6. Adult
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Public Health Programs & Tenders
      2. Hospitals & Specialty Clinics
      3. Primary Care & Decentralized Clinics
      4. Retail Pharmacies
   7. Market Attractiveness Analysis
9. East Asia Hepatitis C Treatment Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Treatment Type
      3. By Clinical Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
      1. Direct-Acting Antivirals
      2. Interferon-Based Therapies
      3. Supportive/Adjunct Therapies
      4. Diagnostics-Plus-Drug Packages
   5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
      1. Pan-Genotypic
      2. Genotype-Specific
      3. Acute
      4. Chronic
      5. Pediatric
      6. Adult
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Public Health Programs & Tenders
      2. Hospitals & Specialty Clinics
      3. Primary Care & Decentralized Clinics
      4. Retail Pharmacies
   7. Market Attractiveness Analysis
10. South Asia & Oceania Hepatitis C Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Treatment Type
       3. By Clinical Indication
       4. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
       1. Direct-Acting Antivirals
       2. Interferon-Based Therapies
       3. Supportive/Adjunct Therapies
       4. Diagnostics-Plus-Drug Packages
    5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
       1. Pan-Genotypic
       2. Genotype-Specific
       3. Acute
       4. Chronic
       5. Pediatric
       6. Adult
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Public Health Programs & Tenders
       2. Hospitals & Specialty Clinics
       3. Primary Care & Decentralized Clinics
       4. Retail Pharmacies
    7. Market Attractiveness Analysis
11. Latin America Hepatitis C Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Treatment Type
       3. By Clinical Indication
       4. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
       1. Direct-Acting Antivirals
       2. Interferon-Based Therapies
       3. Supportive/Adjunct Therapies
       4. Diagnostics-Plus-Drug Packages
    5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
       1. Pan-Genotypic
       2. Genotype-Specific
       3. Acute
       4. Chronic
       5. Pediatric
       6. Adult
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Public Health Programs & Tenders
       2. Hospitals & Specialty Clinics
       3. Primary Care & Decentralized Clinics
       4. Retail Pharmacies
    7. Market Attractiveness Analysis
12. Middle East & Africa Hepatitis C Treatment Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Treatment Type
       3. By Clinical Indication
       4. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Treatment Type, 2025 - 2032
       1. Direct-Acting Antivirals
       2. Interferon-Based Therapies
       3. Supportive/Adjunct Therapies
       4. Diagnostics-Plus-Drug Packages
    5. Market Size (US$ Bn) Analysis and Forecast, By Clinical Indication, 2025 - 2032
       1. Pan-Genotypic
       2. Genotype-Specific
       3. Acute
       4. Chronic
       5. Pediatric
       6. Adult
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Public Health Programs & Tenders
       2. Hospitals & Specialty Clinics
       3. Primary Care & Decentralized Clinics
       4. Retail Pharmacies
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Gilead Sciences
          1. Overview
          2. Segments and Treatment Types
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. AbbVie
       3. Merck & Co.
       4. Bristol-Myers Squibb
       5. Cipla
       6. Mylan
       7. Dr. Reddy’s Laboratories
       8. Zydus Lifesciences
       9. Hetero Healthcare
       10. Natco Pharma
       11. Roche
       12. Pfizer
       13. Johnson & Johnson
       14. Novartis
       15. Teva Pharmaceutical Industries
       16. Apotex
       17. Sun Pharmaceutical Industries
       18. Lupin
       19. Glenmark Pharmaceuticals
       20. Aurobindo Pharma
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations